Orchestra BioMed Holdings Files 10-Q for Q1 2025
Ticker: OBIO · Form: 10-Q · Filed: May 12, 2025 · CIK: 1814114
| Field | Detail |
|---|---|
| Company | Orchestra Biomed Holdings, Inc. (OBIO) |
| Form Type | 10-Q |
| Filed Date | May 12, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, medical-devices
TL;DR
**Orchestra BioMed 10-Q filed! Q1 2025 financials out.**
AI Summary
Orchestra BioMed Holdings, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly Health Sciences Acquisitions Corp, reported financial information for its fiscal quarter. Key financial data and business operations details are included in this filing.
Why It Matters
This filing provides investors with an update on Orchestra BioMed's financial health and operational status for the first quarter of 2025, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a publicly traded company, Orchestra BioMed Holdings, Inc. faces inherent market and operational risks detailed in its SEC filings.
Key Numbers
- 1231 — Fiscal Year End (Indicates the company's annual financial reporting cycle.)
Key Players & Entities
- Orchestra BioMed Holdings, Inc. (company) — Filer of the 10-Q
- Health Sciences Acquisitions Corp (company) — Former name of Orchestra BioMed Holdings, Inc.
- 20250331 (date) — End of the reporting period
- 20250512 (date) — Filing date
FAQ
What is the primary business of Orchestra BioMed Holdings, Inc.?
The filing indicates Orchestra BioMed Holdings, Inc. is in the 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS' industry (SIC code 3841).
When did Orchestra BioMed Holdings, Inc. change its name?
The company changed its name from Health Sciences Acquisitions Corp on June 3, 2020.
What is the SEC file number for Orchestra BioMed Holdings, Inc.?
The SEC file number is 001-39421.
What is the business address of Orchestra BioMed Holdings, Inc.?
The business address is 150 Union Square Drive, New Hope, PA 18938.
What is the reporting period for this 10-Q filing?
The reporting period is March 31, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 12, 2025 regarding Orchestra BioMed Holdings, Inc. (OBIO).